Keller B - Search Results

1

Human T-bet governs the generation of a distinct subset of CD11c^highCD21^low B cells.

Yang R, Avery DT, Jackson KJL, Ogishi M, Benhsaien I, Du L, Ye X, Han J, Rosain J, Peel JN, Alyanakian MA, Neven B, Winter S, Puel A, Boisson B, Payne KJ, Wong M, Russell AJ, Mizoguchi Y, Okada S, Uzel G, Goodnow CC, Latour S, El Bakkouri J, Bousfiha A, Preece K, Gray PE, Keller B, Warnatz K, Boisson-Dupuis S, Abel L, Pan-Hammarström Q, Bustamante J, Ma CS, Casanova JL, Tangye SG. Yang R, et al. Among authors: keller b. Sci Immunol. 2022 Jul 22;7(73):eabq3277. doi: 10.1126/sciimmunol.abq3277. Epub 2022 Jul 22. Sci Immunol. 2022. PMID: 35867801 Free PMC article.

2

Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells.

Rakhmanov M, Keller B, Gutenberger S, Foerster C, Hoenig M, Driessen G, van der Burg M, van Dongen JJ, Wiech E, Visentini M, Quinti I, Prasse A, Voelxen N, Salzer U, Goldacker S, Fisch P, Eibel H, Schwarz K, Peter HH, Warnatz K. Rakhmanov M, et al. Among authors: keller b. Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13451-6. doi: 10.1073/pnas.0901984106. Epub 2009 Jul 29. Proc Natl Acad Sci U S A. 2009. PMID: 19666505 Free PMC article.

3

B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiency.

Foerster C, Voelxen N, Rakhmanov M, Keller B, Gutenberger S, Goldacker S, Thiel J, Feske S, Peter HH, Warnatz K. Foerster C, et al. Among authors: keller b. J Immunol. 2010 Jun 15;184(12):7305-13. doi: 10.4049/jimmunol.1000434. Epub 2010 May 21. J Immunol. 2010. PMID: 20495065

4

Telomere-dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency.

Visentini M, Cagliuso M, Conti V, Carbonari M, Mancaniello D, Cibati M, Siciliano G, Giorda E, Keller B, Warnatz K, Fiorilli M, Quinti I. Visentini M, et al. Among authors: keller b. Eur J Immunol. 2011 Mar;41(3):854-62. doi: 10.1002/eji.201040862. Epub 2011 Feb 2. Eur J Immunol. 2011. PMID: 21287551 Free article.

5

Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency.

Wirsum C, Glaser C, Gutenberger S, Keller B, Unger S, Voll RE, Vach W, Ness T, Warnatz K. Wirsum C, et al. Among authors: keller b. J Clin Immunol. 2016 May;36(4):406-12. doi: 10.1007/s10875-016-0264-7. Epub 2016 Mar 15. J Clin Immunol. 2016. PMID: 26980224

6

B-cell signaling in persistent polyclonal B lymphocytosis (PPBL).

Voelxen N, Wehr C, Gutenberger S, Keller B, Erlacher M, Dominguez-Conde C, Bertele D, Emmerich F, Pantic M, Jennings S, Rakhmanov M, Foerster C, Martens UM, Platzbecker U, Peter HH, Fisch P, Boztug K, Eibel H, Salzer U, Warnatz K. Voelxen N, et al. Among authors: keller b. Immunol Cell Biol. 2016 Oct;94(9):830-837. doi: 10.1038/icb.2016.46. Epub 2016 Apr 29. Immunol Cell Biol. 2016. PMID: 27126628

7

Disturbed canonical nuclear factor of κ light chain signaling in B cells of patients with common variable immunodeficiency.

Keller B, Cseresnyes Z, Stumpf I, Wehr C, Fliegauf M, Bulashevska A, Usadel S, Grimbacher B, Rizzi M, Eibel H, Niesner R, Warnatz K. Keller B, et al. J Allergy Clin Immunol. 2017 Jan;139(1):220-231.e8. doi: 10.1016/j.jaci.2016.04.043. Epub 2016 Jun 14. J Allergy Clin Immunol. 2017. PMID: 27461466

8

Increase of circulating α4β7⁺ conventional memory CD4 and regulatory T cells in patients with common variable immunodeficiency (CVID).

de Melo KM, Unger S, Keller B, Gutenberger S, Stumpf I, Goldacker S, Warnatz K. de Melo KM, et al. Among authors: keller b. Clin Immunol. 2017 Jul;180:80-83. doi: 10.1016/j.clim.2017.03.006. Epub 2017 Mar 18. Clin Immunol. 2017. PMID: 28323147

9

High SYK Expression Drives Constitutive Activation of CD21^low B Cells.

Keller B, Stumpf I, Strohmeier V, Usadel S, Verhoeyen E, Eibel H, Warnatz K. Keller B, et al. J Immunol. 2017 Jun 1;198(11):4285-4292. doi: 10.4049/jimmunol.1700079. Epub 2017 May 3. J Immunol. 2017. PMID: 28468967

10

Preferential Reduction of Circulating Innate Lymphoid Cells Type 2 in Patients with Common Variable Immunodeficiency with Secondary Complications Is Part of a Broader Immune Dysregulation.

Friedmann D, Keller B, Harder I, Schupp J, Tanriver Y, Unger S, Warnatz K. Friedmann D, et al. Among authors: keller b. J Clin Immunol. 2017 Nov;37(8):759-769. doi: 10.1007/s10875-017-0444-0. Epub 2017 Sep 21. J Clin Immunol. 2017. PMID: 28936778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,454 results

Search Page

Filters